Vaccinating Pregnant Women Protects Infants Against Severe RSV
The vaccine RSVpreF had an almost 82% efficacy against severe RSV infection in infants from birth through the first 90 days of life, according to company data.
Thomas Mertens Ortwin Adams Markus Rose Science Media Center Institute For Virology At Ulm University Hospital Institute For Virology Of The University Hospital
Source: medscape.com